Skip to content

Bronchoscopic Argon Plasma Coagulation for Managing Endobronchial Carcinoid Lesions

The Use of Bronchoscopic Argon Plasma Coagulation in Endobronchial Carcinoid

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06757920
Enrollment
40
Registered
2025-01-03
Start date
2025-01-01
Completion date
2025-08-20
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endobronchial Carcinoid

Keywords

Argon Plasma Coagulation, fiberoptic bronchoscopy, endobronchial carcinoid

Brief summary

A small tube will go through the respiratory tract and a non contact cauterization will be done to the inside tumor

Detailed description

fiberoptic bronchoscopy will go through the tracheobronchial tree and after localization of the tumor, argon plasma coagulation by initiation non contact electrocautery will be done to the tumor

Interventions

PROCEDUREbronchoscopic argon plasma coagulation

Argon Plasma Cogulation for Debulking Endobronchial Carcinoid Using Fiberoptic Bronchoscopy

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Argon Plasma Coagulation via non contact probe for debulking and fulgration of the endobronchial carcinoid using fiberoptic bronchoscopy

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1 - Cooperative patient with written informed consent. 2- Patients diagnosed with endobronchial carcinoid. 3- Patients fit for fiberoptic bronchoscopy. 4- Patients unwilling or unfit for surgery.

Exclusion criteria

1 -Poor karnofsky score. 2- Patients unwilling or unfit for bronchoscopy. 3- Extraluminal lesion. 4- Patients with pacemaker. 5- Forced expiratory volume 1 is less than one litre.

Design outcomes

Primary

MeasureTime frameDescription
Dyspnea Borg Scaleone monthscale from 0 to 4 according to the degree of improvement

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026